Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRX215 for Liver Regeneration After PVE in Colorectal Liver Metastasis
NCT07612007Phase 2Not yet recruiting
- Sponsor
- Mayo Clinic
- Start
- Dec 2026
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
A Phase 2 trial of darizmetinib in colorectal cancer with liver metastasis (CRLM), sponsored by Mayo Clinic. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
darizmetinib
03
Conditions
colorectal cancer with liver metastasis (CRLM)
Beyond the preview
Go deeper on NCT07612007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07612007.